Is Microneedling Worth It for Hair?

How Microneedling Promotes Hair Regrowth

Microneedling creates controlled micro-injuries in the scalp using fine needles between 0.25 mm and 2.5 mm in length. These punctures trigger a wound-healing cascade that releases platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF), and Wnt signaling proteins, all of which activate dormant hair follicle stem cells 1. A 2021 systematic review of 22 studies confirmed that microneedling upregulates these growth factors at dermal papilla cells, providing a biological rationale distinct from topical therapies 2.

The procedure also disrupts the fibrotic layer beneath miniaturized follicles. Perifollicular fibrosis is a recognized contributor to follicle miniaturization in androgenetic alopecia (AGA), and the needle-induced collagen remodeling may physically loosen that barrier 3. A separate mechanism involves enhanced drug absorption. Microneedling channels increase transdermal delivery of topical minoxidil by up to 1.5-fold according to pharmacokinetic modeling 4. This dual action, biological stimulation plus improved drug penetration, explains why combination therapy outperforms either intervention alone.

The Landmark Dhurat 2013 Trial

The study that put scalp microneedling on the clinical map was a randomized controlled trial published by Dhurat et al. in 2013. One hundred men with AGA (Norwood-Hamilton grades II to IV) were assigned to microneedling plus 5% minoxidil or minoxidil alone 5. Subjects in the microneedling arm received weekly sessions with a 1.5 mm dermaroller.

At 12 weeks, the microneedling group gained a mean of 91.4 hairs in the target area compared to 22.2 in the minoxidil-only group (P<0.001) 5. That is a roughly fourfold advantage. Investigator-assessed photographs rated 82% of the microneedling group as showing moderate-to-marked improvement versus 17% for minoxidil alone. No serious adverse events were reported. The trial had limitations: it was single-center, enrolled only men, and lacked blinding of evaluators. Still, its effect size was large enough to influence subsequent research directions globally.

What Later Trials Have Confirmed

Multiple RCTs since 2013 have replicated these findings with variations in protocol. A 2020 trial by Faghihi et al. (N=60) compared microneedling plus minoxidil to minoxidil plus platelet-rich plasma (PRP) and found statistically similar hair density gains in both arms at 12 weeks, suggesting microneedling can match PRP when paired with topical therapy 6.

A 2022 meta-analysis in the Journal of the American Academy of Dermatology pooled data from 11 RCTs (N=459 subjects) and concluded that adjunctive microneedling significantly improved total hair density (weighted mean difference: +16.81 hairs per cm², 95% CI 11.84 to 21.78) over conventional medical therapy alone 7. The confidence intervals did not cross zero in any sensitivity analysis.

A 2023 systematic review published in Dermatologic Surgery examined 16 controlled studies and found consistent superiority of microneedling combinations over monotherapy across both sexes and across AGA severity grades 8. Heterogeneity remained high because of variation in needle depth, session frequency, and measurement methods, but the direction of the effect was uniform.

Needle Depth, Frequency, and Protocol Details

Needle depth matters. Depths below 0.5 mm do not reliably reach the dermal papilla or trigger sufficient wound healing for hair outcomes 9. Most positive hair-loss trials used 1.0 to 1.5 mm. A comparative study by Bao et al. (2023) found that 1.5 mm produced statistically greater hair density improvements than 0.6 mm at 24 weeks 10.

Session frequency in the literature ranges from weekly to biweekly. The Dhurat protocol used weekly sessions. Some clinicians space treatments every 10 to 14 days to allow complete re-epithelialization, which typically takes 48 to 72 hours at 1.5 mm depth. The American Academy of Dermatology does not yet publish a formal microneedling-for-hair guideline, but expert consensus from a 2022 Delphi panel recommended sessions every one to two weeks with 1.0 to 1.5 mm needles for AGA 11.

At-home dermarollers typically max out at 0.5 mm and require more frequent use (two to three times per week). The evidence base for at-home devices is thinner. A small pilot (N=20) showed modest improvement with 0.5 mm home dermarolling plus minoxidil, but the results fell short of the gains seen with 1.5 mm in-office protocols 12.

For topical application after a session, most protocols instruct patients to wait 12 to 24 hours before applying minoxidil to avoid systemic absorption through open channels.

Microneedling Combined with Finasteride

Most published trials pair microneedling with minoxidil, but emerging data support combining it with finasteride as well. A 2021 open-label trial (N=68) compared microneedling plus oral finasteride 1 mg to finasteride alone in men with AGA 13. At 24 weeks, the combination group showed a 20% greater increase in hair density than the finasteride-only group (P=0.003).

Finasteride works by reducing scalp dihydrotestosterone (DHT) concentrations by approximately 60% at the standard 1 mg daily dose 14. Microneedling addresses a different pathway, growth factor stimulation and fibrosis disruption, so the combination is mechanistically complementary rather than redundant. For patients who respond partially to finasteride alone, adding microneedling offers a non-hormonal adjunct that does not compound the androgen-related side effect profile.

Does It Work for Women?

Female pattern hair loss (FPHL) affects up to 40% of women by age 50 according to epidemiological data 15. Topical minoxidil 5% is the most studied treatment for FPHL, with the FDA having approved the 2% formulation for women 16.

Data on microneedling in women are more limited but consistently positive. A 2020 pilot RCT (N=40 women with FPHL) randomized subjects to microneedling plus 5% minoxidil versus minoxidil alone 17. At 12 weeks, the microneedling arm achieved significantly greater hair density (P=0.02) and higher patient satisfaction scores. No androgenetic side effects occurred because microneedling is hormone-neutral.

The Endocrine Society's 2019 guideline on female hair loss mentions microneedling as an adjunctive option worth considering, though it stops short of a formal recommendation pending larger trials 18. For women who cannot use finasteride (contraindicated in pregnancy and not FDA-approved for female AGA), microneedling fills a real gap as a non-hormonal augmentation strategy.

Safety, Side Effects, and Who Should Avoid It

Microneedling is well tolerated in most clinical settings. The most common side effects are transient scalp erythema lasting 24 to 48 hours and mild pinpoint bleeding during the procedure 7. A pooled safety analysis across nine RCTs reported zero serious adverse events attributable to microneedling, though one case of localized contact dermatitis was noted in a patient who applied minoxidil too soon after a session 8.

Absolute contraindications include active scalp infections (bacterial or fungal), bleeding disorders, and anticoagulant therapy at therapeutic doses. Relative contraindications include keloid-prone skin, active scalp psoriasis plaques, and use of systemic isotretinoin (which impairs wound healing) 19. Patients on isotretinoin should wait at least six months after completing the course before starting microneedling.

Infection risk is real but uncommon. Proper sterilization of the dermaroller or use of single-use cartridge pen tips minimizes this concern. The FDA classifies microneedling devices as Class II medical devices requiring 510(k) clearance 20.

Cost, Access, and Realistic Expectations

In-office microneedling sessions for hair typically cost $200 to $700 per visit depending on geography and whether PRP is added. Most protocols recommend 6 to 12 initial sessions followed by monthly maintenance. That means a first-year total of roughly $1,200 to $8,400 for in-office treatment.

At-home dermarollers (0.25 to 0.5 mm) cost $15 to $40 and may offer a lower-cost entry point, though the evidence base is weaker. A reasonable approach for motivated patients: start with in-office 1.5 mm sessions every two weeks for three months, then transition to monthly in-office maintenance supplemented by at-home 0.5 mm rolling between visits.

Set expectations clearly. Microneedling does not resurrect fully miniaturized, scarred follicles. Patients with Norwood V to VII or Ludwig III patterns are less likely to see cosmetically meaningful regrowth 7. The best candidates have early to moderate AGA with follicles that still produce vellus or intermediate hairs.

Visible improvement generally appears between weeks 8 and 12, with continued gains through week 24. A 2023 retrospective series (N=112 patients) documented that 73% of responders achieved their peak density improvement between months 4 and 6 8.

How Microneedling Compares to PRP and Low-Level Laser Therapy

Patients often ask how microneedling stacks up against other adjunctive treatments. PRP involves drawing blood, centrifuging it to concentrate platelets, and injecting the concentrate into the scalp. A 2019 meta-analysis (N=6 RCTs, 194 patients) found that PRP improved hair density by a mean of 27.7 hairs per cm² over baseline 21. The 2022 microneedling meta-analysis showed a comparable +16.81 hairs per cm² advantage over active comparators, not over baseline, making direct comparison difficult 7.

Low-level laser therapy (LLLT) using 650 to 900 nm wavelengths has FDA clearance for hair growth. A 2014 RCT (N=128) of a 655 nm helmet device showed a 20.2 hairs per cm² increase over 16 weeks versus sham 22. LLLT is painless and home-based but requires 3 to 4 sessions per week for ongoing use.

No head-to-head RCT has compared all three modalities. The Faghihi 2020 trial mentioned earlier is the closest, finding microneedling plus minoxidil roughly equivalent to PRP plus minoxidil at 12 weeks 6. Microneedling has the practical advantage of lower per-session cost compared to PRP ($200 to $700 vs. $500 to $1,500) and does not require blood draws.

The Bottom Line on Value

For patients with early to moderate androgenetic alopecia who are already using minoxidil or finasteride, adding microneedling at 1.0 to 1.5 mm depth every one to two weeks is supported by Level 2 evidence (multiple RCTs, one meta-analysis). The number needed to treat has not been formally calculated, but absolute hair density gains of 40 to 90 hairs per cm² over 12 to 24 weeks are consistently reported in combination protocols 5 7. Starting 1.5 mm microneedling sessions biweekly for three months, combined with daily topical minoxidil 5% (applied 24 hours after each needling session), represents the best-supported protocol based on current RCT data 11.